Neuroprotective drug study for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is testing whether a medicine called edaravone can help people who recently had a mild or moderate stroke caused by a blocked blood vessel in the brain. It aims to see if the drug improves recovery when given within the first two days after stroke symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had an ischemic stroke (a blood clot blocking a blood vessel in the brain) in the front part of the brain within the last 48 hours.
- Your stroke is mild or moderate – a score of 1 to 15 on a standard stroke scale (NIHSS).
- Before the stroke, you were independent and able to care for yourself (score 0 or 1 on the mRS scale).
- You are willing to receive the study medicine, edaravone, as an injection or tablet.
- You do not have bleeding in the brain, serious heart conditions, or significant liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called edaravone dexborneol to see if it helps people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel). The medicine is given within 48 hours of the stroke, and the study will compare how well it works and if it is safe.
This trial tests a medication called edaravone dexborneol that is given under the tongue while you are being transferred to a hospital for a procedure to remove a blood clot from your brain. It is hoped that this medication can help protect your brain during the journey and improve recovery after the stroke.
This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests whether adding anisodine, a medicine that may protect brain cells, helps people recover better after a stroke caused by a blocked large artery in the brain. It is given after a procedure to remove the clot.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.